Ignite Creation Date:
2024-05-06 @ 8:20 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06347562
Status:
RECRUITING
Last Update Posted:
2024-04-04
First Post:
2024-03-21
Brief Title:
Optical Genome Mapping for the Diagnosis of Neurodevelopmental Disorders
Sponsor:
IRCCS Eugenio Medea
Organization:
IRCCS Eugenio Medea
Study Overview
Official Title:
Next Generation Cytogenetics Impact of New Technologies in the Genetic Diagnosis of Neurodevelopmental Disorders
Status:
RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
to evaluate the ability of the Optical genome Mapping OGM approach to detect simple and complex constitutional chromosomal aberrations of clinical relevance which had previously been identified with standard diagnostic approaches karyotyping FISH CNV-microarray in the context of neurodevelopmental disorders NDDs withwo congenital anomalies CA
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None